Year archive

Ocumension Therapeutics — 2020 filings

All 37 regulatory filings released by Ocumension Therapeutics (1477) in 2020, sourced directly from the official regulator.

37 Filings

2020 Period

2020 filings (37)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED IN THE PHASE III CLINICAL TRIAL OF OT-1001 (ZERVIATE) IN CHINA Regulatory Filings	2020-12-29	English
VOLUNTARY ANNOUNCEMENT OT-401 APPROVED FOR REAL WORLD STUDY IN HAINAN BOAO Regulatory Filings	2020-12-28	English
CHANGE OF ADDRESS OF HEAD OFFICE AND PRINCIPAL PLACE OF BUSINESS IN THE PRC Regulatory Filings	2020-12-28	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 November 2020 Capital/Financing Update	2020-12-03	English
VOLUNTARY ANNOUNCEMENT INITIATION OF OT-401 REAL WORLD STUDY IN HAINAN Regulatory Filings	2020-11-30	English
VOLUNTARY ANNOUNCEMENT INITIATION OF SECOND PHASE III CLINICAL TRIAL OF OT-301 IN THE UNITED STATES Regulatory Filings	2020-11-11	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2020 Share Issue/Capital Change	2020-11-05	English
VOLUNTARY ANNOUNCEMENT ENTERING INTO COLLABORATION AND EXCLUSIVE PROMOTION AGREEMENT WITH LUYE PHARMA Capital/Financing Update	2020-10-29	English
VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL TRIAL OF OT-301 (NCX 470) APPROVED IN CHINA Regulatory Filings	2020-10-23	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2020 Share Issue/Capital Change	2020-10-07	English
Notification Letter and Request Form for Non-Registered Shareholders Report Publication Announcement	2020-09-29	English
Letter to Shareholders - Election of Language and Means of Receipt of Corporate Communications Regulatory Filings	2020-09-29	English
ELECTION OF LANGUAGE AND MEANS OF RECEIPT OF CORPORATE COMMUNICATIONS Regulatory Filings	2020-09-29	English
2020 Interim Report Regulatory Filings	2020-09-29	English
VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL TRIAL OF OT-1001 (ZERVIATE) APPROVED IN CHINA Regulatory Filings	2020-09-22	English
ANNOUNCEMENT ACQUISITION OF 100% EQUITY INTEREST IN SUZHOU XIAXIANG AND CHANGE IN USE OF PROCEEDS FROM THE LISTING Capital/Financing Update	2020-09-11	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 August 2020 Regulatory Filings	2020-09-03	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2020 Interim / Quarterly Report	2020-08-26	English
NOTICE OF BOARD MEETING Regulatory Filings	2020-08-14	English
Next Day Disclosure Return Share Issue/Capital Change	2020-08-05	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 July 2020 Capital/Financing Update	2020-08-05	English
FULL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD Capital/Financing Update	2020-08-02	English
List of Directors and their Role and Function Board/Management Information	2020-07-09	English
TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE Remuneration Information	2020-07-09	English
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE Governance Information	2020-07-09	English
TERMS OF REFERENCE OF THE AUDIT COMMITTEE Governance Information	2020-07-09	English
AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Governance Information	2020-07-09	English
ANNOUNCEMENT OF OFFER PRICE AND ALLOTMENT RESULTS Regulatory Filings	2020-07-09	English
GREEN APPLICATION FORM Capital/Financing Update	2020-06-29	English
YELLOW APPLICATION FORM Share Issue/Capital Change	2020-06-29	English
WHITE APPLICATION FORM Capital/Financing Update	2020-06-29	English
GLOBAL OFFERING Regulatory Filings	2020-06-29	English
GLOBAL OFFERING Capital/Financing Update	2020-06-29	English
PHIP (1st submission) Audit Report / Information FY 2020	2020-06-21	English
PHIP (1st submission) Regulatory Filings	2020-06-21	English
Application Proof (1st submission) Audit Report / Information FY 2019	2020-04-29	English
Application Proof (1st submission) Regulatory Filings	2020-04-29	English